maps.org Reviews

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a well-established and reputable non-profit organization that has been operating for over three decades. It is dedicated to advancing research and education in the field of psychedelic medicine. MAPS has a strong track record of conducting rigorous scientific studies and has made significant contributions to the understanding of the therapeutic potential of psychedelics, particularly in the treatment of mental health conditions such as PTSD. The organization has also been involved in advocacy efforts to promote evidence-based policies related to psychedelics and marijuana. MAPS has received substantial funding from philanthropic donors and grantors, which further underscores its credibility and support within the scientific and medical communities. Additionally, the organization’s leadership, including its founder, Rick Doblin, Ph.D., and its board of directors, consists of respected professionals with expertise in relevant fields. MAPS’ work has been widely covered in reputable media outlets and has been presented at prestigious scientific conferences. Overall, MAPS is recognized as a leading authority in the field of psychedelic research and has played a pivotal role in advancing the understanding and acceptance of psychedelic-assisted therapy.”

the reasons behind this review :
Long-standing reputation and credibility in the field of psychedelic research and education. Strong track record of conducting rigorous scientific studies. Significant contributions to the understanding of the therapeutic potential of psychedelics, particularly in the treatment of mental health conditions such as PTSD. Involvement in advocacy efforts to promote evidence-based policies related to psychedelics and marijuana. Substantial funding from philanthropic donors and grantors. Leadership, including founder Rick Doblin, Ph.D., and board of directors, consists of respected professionals with expertise in relevant fields. Widely covered in reputable media outlets and presented at prestigious scientific conferences. Recognized as a leading authority in the field of psychedelic research and has played a pivotal role in advancing the understanding and acceptance of psychedelic-assisted therapy.